DIHYDROCODEINE BITARTRATE — Competitive Intelligence Brief

DIHYDROCODEINE BITARTRATE (DIHYDROCODEINE BITARTRATE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Central Nervous System Stimulant [EPC].

marketed Central Nervous System Stimulant [EPC] Small molecule

Target snapshot

DIHYDROCODEINE BITARTRATE (DIHYDROCODEINE BITARTRATE).

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
DIHYDROCODEINE BITARTRATE TARGET	DIHYDROCODEINE BITARTRATE		marketed	Central Nervous System Stimulant [EPC]		1983-01-01
Vyvanse	LISDEXAMFETAMINE	Takeda	marketed	Central Nervous System Stimulant	Sodium-dependent dopamine transporter	2007-01-01
Focalin	DEXMETHYLPHENIDATE	Novartis	marketed	Central Nervous System Stimulant	Sodium-dependent dopamine transporter	2001-01-01
PYRILAMINE	PYRILAMINE		marketed	Central Nervous System Stimulant [EPC]		1973-01-01
Pyrilamine	mepyramine	Impax Labs	marketed	Central Nervous System Stimulant [EPC]	Histamine H1 receptor	1973-01-01
PYRILAMINE MALEATE	PYRILAMINE MALEATE		marketed	Central Nervous System Stimulant [EPC]		1973-01-01
Synalgos-Dc	DIHYDROCODEINE	Caraco	marketed	Central Nervous System Stimulant [EPC]	Mu-type opioid receptor	1958-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Central Nervous System Stimulant [EPC] class)

1. · 5 drugs in this class
2. Caraco · 1 drug in this class
3. Hikma · 1 drug in this class
4. Impax Labs · 1 drug in this class
5. Second Affiliated Hospital, School of Medicine, Zhejiang University · 1 drug in this class
6. UCB · 1 drug in this class
7. University of Colorado, Denver · 1 drug in this class